勝利精密(002426.SZ)非公開發行股票方案到期失效
格隆匯2月21日丨勝利精密(002426.SZ)公佈,公司於2019年1月10日召開了第四屆董事會第十八次會議、第四屆監事會第十七次會議,於2019年2月21日召開了2019年第一次股東大會,審議通過了《關於公司非公開發行股票方案的議案》等相關議案,本次非公開發行決議的有效期為股東大會審議通過之日起12個月。
自上述方案通過審議後,公司一直積極推進材料申報有關事宜,因資本市場環境和融資時機變化等因素,本次非公開發行股票事項尚未取得實質進展。截至2020年2月20日,公司本次非公開發行股票方案到期自動失效,該事項不會對公司生產經營造成重大影響。未來公司將根據自身戰略發展需求及資金需求狀況,制定相應的資本市場融資計劃。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.